Average Co-Inventor Count = 5.97
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (35 from 444 patents)
2. Icahn School of Medicine at Mount Sinai (6 from 270 patents)
3. Dana-farber-cancer Institute Inc. (2 from 1,209 patents)
4. Arbutus Biopharma Corporation (57 patents)
35 patents:
1. 12492401 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
2. 12467051 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
3. 12460206 - PCSK9 iRNA compositions and methods of use thereof
4. 11866709 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
5. 11840692 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
6. 11834662 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
7. 11525138 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
8. 11446380 - Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
9. 11408001 - Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
10. 11332743 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
11. 11306316 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
12. 11306314 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
13. 11306315 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
14. 11198872 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
15. 11142766 - Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof